Search Results

Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory committee.

Leerink analysts warned that Kennedy’s remarks to FDA staff would likely be a negative for the biotech industry.

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.

FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s advisory committees. But not only do company reps serve only as non-voting members, a 1997 law actually requires industry involvement.

The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.

At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, announced it has acquired Norman, Oklahoma-based Bio-Cide International, Inc., a leading multi-specialty source of chlorine dioxide-based antimicrobial technology.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, with its subsidiary Kemin Biologics, has signed an exclusive agreement with Pacific GeneTech (PGT) to license PGT’s TMH001 Eimeria vaccine for poultry